Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,471,000 | $2,388,000 | $2,064,026 | $2,295,869 |
| Dep. & Amort. | $1,050,000 | $1,039,000 | $1,016,212 | $936,603 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $58,500 | $0 |
| Change in WC | $733,000 | -$2,336,000 | $184,000 | -$87,310 |
| Other Non-Cash | $5,042,000 | $714,000 | $397,447 | $1,166,786 |
| Operating Cash Flow | $3,354,000 | $1,805,000 | $3,720,184 | $2,438,741 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,397,000 | -$1,197,000 | -$2,644,718 | -$2,834,614 |
| Net Acquisitions | -$87,000 | $0 | -$29,627 | -$3,292,995 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $59,000 | -$1,594,000 | -$582,668 | $5,953 |
| Investing Cash Flow | -$2,425,000 | -$2,791,000 | -$3,257,013 | -$6,121,656 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,475,000 | $2,622,000 | -$9,337 | $359,705 |
| Stock Issued | $0 | $0 | $0 | -$93,263 |
| Stock Repurch. | -$6,000 | -$62,000 | -$4,000 | -$51,593 |
| Dividends Paid | $0 | -$1,601,000 | $0 | -$83,265 |
| Other Fin. Act. | $1,360,000 | $0 | -$128,163 | -$1,096,342 |
| Financing Cash Flow | -$1,121,000 | $959,000 | -$141,500 | $3,875,395 |
| Forex Effect | -$203,000 | -$389,000 | $0 | $825,234 |
| Net Chg. in Cash | -$395,000 | $6,804,000 | -$7,620,000 | $1,017,714 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,804,000 | $0 | $11,453,861 | $10,489,412 |
| End Cash | $6,409,000 | $6,804,000 | $12,183,676 | $11,507,126 |
| Free Cash Flow | $1,975,000 | $608,000 | $2,115,379 | -$395,874 |